Loading clinical trials...
Loading clinical trials...
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Conditions
Interventions
SADBE
Placebo
Locations
5
United States
Stanford Medicine Outpatient Center
Redwood City, California, United States
International Research Partners, LLC
Doral, Florida, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Quality Clinical Research, Inc
Omaha, Nebraska, United States
Advantage Clinical Trials
The Bronx, New York, United States
Start Date
December 1, 2016
Primary Completion Date
December 20, 2018
Completion Date
December 20, 2018
Last Updated
November 2, 2021
NCT06734728
NCT03977792
NCT00306293
NCT03310294
NCT03307772
NCT02207881
Lead Sponsor
Squarex, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions